Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-amygdala Infusions of D-cycloserine As Assessed with Fear-potentiated Startle in Rats

Overview

Journal J Neurosci

Specialty Neurology

Date 2002 Mar 16

PMID 11896173

Citations 333

Authors

David L Walker

Kerry J Ressler

Kwok-Tung Lu

Michael Davis

Affiliations

Soon will be listed here.

Abstract

NMDA receptor antagonists block conditioned fear extinction when injected systemically and also when infused directly into the amygdala. Here we evaluate the ability of D-cycloserine (DCS), a partial agonist at the strychnine-insensitive glycine-recognition site on the NMDA receptor complex, to facilitate conditioned fear extinction after systemic administration or intra-amygdala infusions. Rats received 10 pairings of a 3.7 sec light and a 0.4 mA footshock (fear conditioning). Fear-potentiated startle (increased startle in the presence vs the absence of the light) was subsequently measured before and after 30, 60, or 90 presentations of the light without shock (extinction training). Thirty non-reinforced light presentations produced modest extinction, and 60 or 90 presentations produced nearly complete extinction (experiment 1). DCS injections (3.25, 15, or 30 mg/kg) before 30 non-reinforced light exposures dose-dependently enhanced extinction (experiment 2) but did not influence fear-potentiated startle in rats that did not receive extinction training (experiment 3). These effects were blocked by HA-966, an antagonist at the glycine-recognition site (experiment 4). Neither DCS nor HA-966 altered fear-potentiated startle when injected before testing (experiment 5). The effect of systemic administration was mimicked by intra-amygdala DCS (10 microg/side) infusions (experiment 6). These results indicate that treatments that promote NMDA receptor activity after either systemic or intra-amygdala administration promote the extinction of conditioned fear.

Citing Articles

Computational modeling design of novel NMDAR agonist for the treatment of Schizophrenia.

Manica A, Daud M, Faloyo M, Akinwunmi A, Adekunle A, Adekola A Neurogenetics. 2025; 26(1):18.

PMID: 39762449 DOI: 10.1007/s10048-024-00796-2.

NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models.

Tumdam R, Hussein Y, Garin-Shkolnik T, Stern S Int J Mol Sci. 2024; 25(22).

PMID: 39596430 PMC: 11594297. DOI: 10.3390/ijms252212366.

Memory persistence: from fundamental mechanisms to translational opportunities.

Merlo S, Belluscio M, Eugenia Pedreira M, Merlo E Transl Psychiatry. 2024; 14(1):98.

PMID: 38355584 PMC: 10867010. DOI: 10.1038/s41398-024-02808-z.

Mechanisms of alcohol influence on fear conditioning: a computational model.

Lonnberg A, Logrip M, Kuznetsov A bioRxiv. 2024; .

PMID: 38260700 PMC: 10802259. DOI: 10.1101/2023.12.30.573310.

Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.

Heresco-Levy U, Lerer B Mol Psychiatry. 2023; 29(1):146-152.

PMID: 37945694 DOI: 10.1038/s41380-023-02312-8.

References

Cassella J, Harty T, Davis M . Fear conditioning, pre-pulse inhibition and drug modulation of a short latency startle response measured electromyographically from neck muscles in the rat. Physiol Behav. 1986; 36(6):1187-91. DOI: 10.1016/0031-9384(86)90499-3. View

Klodzinska A, Chojnacka-Wojcik E . Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis. Psychopharmacology (Berl). 2000; 152(2):224-8. DOI: 10.1007/s002130000547. View

Quartermain D, Mower J, Rafferty M, HERTING R, Lanthorn T . Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol. 1994; 257(1-2):7-12. DOI: 10.1016/0014-2999(94)90687-4. View

Dadds M, Bovbjerg D, Redd W, Cutmore T . Imagery in human classical conditioning. Psychol Bull. 1997; 122(1):89-103. DOI: 10.1037/0033-2909.122.1.89. View

Moraes Ferreira V, Morato G . D-cycloserine blocks the effects of ethanol and HA-966 in rats tested in the elevated plus-maze. Alcohol Clin Exp Res. 1998; 21(9):1638-42. View

Olney J . New mechanisms of excitatory transmitter neurotoxicity. J Neural Transm Suppl. 1994; 43:47-51. View

Fyer A . Current approaches to etiology and pathophysiology of specific phobia. Biol Psychiatry. 1998; 44(12):1295-304. DOI: 10.1016/s0006-3223(98)00274-1. View

Morgan 3rd C, Grillon C, Southwick S, Davis M, Charney D . Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry. 1995; 38(6):378-85. DOI: 10.1016/0006-3223(94)00321-S. View

Lu K, Walker D, Davis M . Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. J Neurosci. 2001; 21(16):RC162. PMC: 6763147. View

10.

Tang Y, Shimizu E, Dube G, Rampon C, Kerchner G, Zhuo M . Genetic enhancement of learning and memory in mice. Nature. 1999; 401(6748):63-9. DOI: 10.1038/43432. View

11.

Schwartz B, Hashtroudi S, HERTING R, Schwartz P, Deutsch S . d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology. 1996; 46(2):420-4. DOI: 10.1212/wnl.46.2.420. View

12.

Foa E . Psychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry. 2000; 61 Suppl 5:43-8; discussion 49-51. View

13.

FLOOD J, Morley J, Lanthorn T . Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol. 1992; 221(2-3):249-54. DOI: 10.1016/0014-2999(92)90709-d. View

14.

Goff D, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld D . A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999; 56(1):21-7. DOI: 10.1001/archpsyc.56.1.21. View

15.

Cox J, Westbrook R . The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat. Q J Exp Psychol B. 1994; 47(2):187-210. View

16.

Watson G, Bolanowski M, Baganoff M, Deppeler C, Lanthorn T . D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res. 1990; 510(1):158-60. DOI: 10.1016/0006-8993(90)90745-w. View

17.

Priestley T, Kemp J . Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex. Mol Pharmacol. 1994; 46(6):1191-6. View

18.

Walz R, Roesler R, Barros D, de Souza M, Rodrigues C, SantAnna M . Effects of post-training infusions of a mitogen-activated protein kinase kinase inhibitor into the hippocampus or entorhinal cortex on short- and long-term retention of inhibitory avoidance. Behav Pharmacol. 2000; 10(8):723-30. DOI: 10.1097/00008877-199912000-00003. View

19.

Emmett M, Mick S, Cler J, Rao T, Iyengar S, Wood P . Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology. 1991; 30(11):1167-71. DOI: 10.1016/0028-3908(91)90161-4. View

20.

Bouton M, Mineka S, Barlow D . A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001; 108(1):4-32. DOI: 10.1037/0033-295x.108.1.4. View